219 related articles for article (PubMed ID: 31275795)
1. Conjugates of Cryptophycin and RGD or
Borbély A; Figueras E; Martins A; Bodero L; Raposo Moreira Dias A; López Rivas P; Pina A; Arosio D; Gallinari P; Frese M; Steinkühler C; Gennari C; Piarulli U; Sewald N
ChemistryOpen; 2019 Jun; 8(6):737-742. PubMed ID: 31275795
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting.
Bodero L; López Rivas P; Korsak B; Hechler T; Pahl A; Müller C; Arosio D; Pignataro L; Gennari C; Piarulli U
Beilstein J Org Chem; 2018; 14():407-415. PubMed ID: 29520305
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α
Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U
ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.
Borbély A; Figueras E; Martins A; Esposito S; Auciello G; Monteagudo E; Di Marco A; Summa V; Cordella P; Perego R; Kemker I; Frese M; Gallinari P; Steinkühler C; Sewald N
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30939768
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates.
Borbély A; Thoreau F; Figueras E; Kadri M; Coll JL; Boturyn D; Sewald N
Chemistry; 2020 Feb; 26(12):2602-2605. PubMed ID: 31943410
[TBL] [Abstract][Full Text] [Related]
7. Cyclic RGD and
Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
[TBL] [Abstract][Full Text] [Related]
8. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α
Raposo Moreira Dias A; Pina A; Dal Corso A; Arosio D; Belvisi L; Pignataro L; Caruso M; Gennari C
Chemistry; 2017 Oct; 23(58):14410-14415. PubMed ID: 28816404
[TBL] [Abstract][Full Text] [Related]
9. Tumor Targeting with an isoDGR-Drug Conjugate.
Zanella S; Angerani S; Pina A; López Rivas P; Giannini C; Panzeri S; Arosio D; Caruso M; Gasparri F; Fraietta I; Albanese C; Marsiglio A; Pignataro L; Belvisi L; Piarulli U; Gennari C
Chemistry; 2017 Jun; 23(33):7910-7914. PubMed ID: 28449309
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin α
Paulus J; Sewald N
Front Chem; 2022; 10():869639. PubMed ID: 35480387
[TBL] [Abstract][Full Text] [Related]
11. RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index.
Paulus J; Nachtigall B; Meyer P; Sewald N
Chemistry; 2023 Feb; 29(12):e202203476. PubMed ID: 36454662
[TBL] [Abstract][Full Text] [Related]
12. αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology.
Dal Corso A; Pignataro L; Belvisi L; Gennari C
Curr Top Med Chem; 2016; 16(3):314-29. PubMed ID: 26126915
[TBL] [Abstract][Full Text] [Related]
13. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates.
Anselmi M; Borbély A; Figueras E; Michalek C; Kemker I; Gentilucci L; Sewald N
Chemistry; 2021 Jan; 27(3):1015-1022. PubMed ID: 32955139
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase as a versatile cleavage enzyme for activation of αvβ3 integrin-targeted small molecule drug conjugates with different payload classes in the tumor microenvironment.
Rebstock AS; Wiedmann M; Stelte-Ludwig B; Wong H; Johnson AJ; Izumi R; Hamdy A; Lerchen HG
Front Pharmacol; 2024; 15():1358393. PubMed ID: 38495100
[No Abstract] [Full Text] [Related]
15. Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.
Sernissi L; Trabocchi A; Scarpi D; Bianchini F; Occhiato EG
Bioorg Med Chem; 2016 Feb; 24(4):703-11. PubMed ID: 26753814
[TBL] [Abstract][Full Text] [Related]
16. Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists.
Panzeri S; Zanella S; Arosio D; Vahdati L; Dal Corso A; Pignataro L; Paolillo M; Schinelli S; Belvisi L; Gennari C; Piarulli U
Chemistry; 2015 Apr; 21(16):6265-71. PubMed ID: 25761230
[TBL] [Abstract][Full Text] [Related]
17. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
[TBL] [Abstract][Full Text] [Related]
18. Optimizing the enzymatic release of MMAE from
Zambra M; Ranđelović I; Talarico F; Borbély A; Svajda L; Tóvári J; Mező G; Bodero L; Colombo S; Arrigoni F; Fasola E; Gazzola S; Piarulli U
Front Pharmacol; 2023; 14():1215694. PubMed ID: 37492088
[TBL] [Abstract][Full Text] [Related]
19. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
Arosio D; Manzoni L; Corno C; Perego P
Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of RGD peptidomimetic - Gold nanostar conjugates as M21 cell adhesion inhibitors.
Innocenti R; Dallari C; Lenci E; Pavone FS; Bianchini F; Credi C; Trabocchi A
Bioorg Chem; 2022 Sep; 126():105873. PubMed ID: 35598570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
